Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Gnarra

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesisN de Paulsen, A Brychzy, M C Fournier, et al.
The Urologic Clinics of North America|May 1, 1993
Molecular genetic studies of sporadic and familial renal cell carcinomaJ R Gnarra, G M Glenn, F Latif, et al.
Human Pathology|May 1, 1997
von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau diseaseA O Vortmeyer, J R Gnarra, M R Emmert-Buck, et al.
Cancer Research|June 15, 1993
Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumorsM Makos, B D Nelkin, R E Reiter, et al.
Human Mutation|January 1, 1995
Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotypeF Chen, T Kishida, M Yao, et al.
Nature Genetics|May 1, 1994
Mutations of the VHL tumour suppressor gene in renal carcinomaJ R Gnarra, K Tory, Y Weng, et al.
Oncogene|June 1, 1994
Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell linesY Sekido, S Bader, F Latif, et al.
Oncogene|January 1, 1994
Examination of human tumors for rhoA mutationsJ A Moscow, R He, J R Gnarra, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 1995
Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutationsD R Duan, J S Humphrey, D Y Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1996
Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor geneJ R Gnarra, S Zhou, M J Merrill, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesisN de Paulsen, A Brychzy, M C Fournier, et al.
The Urologic Clinics of North America|May 1, 1993
Molecular genetic studies of sporadic and familial renal cell carcinomaJ R Gnarra, G M Glenn, F Latif, et al.
Human Pathology|May 1, 1997
von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau diseaseA O Vortmeyer, J R Gnarra, M R Emmert-Buck, et al.
Cancer Research|June 15, 1993
Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumorsM Makos, B D Nelkin, R E Reiter, et al.
Human Mutation|January 1, 1995
Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotypeF Chen, T Kishida, M Yao, et al.
Nature Genetics|May 1, 1994
Mutations of the VHL tumour suppressor gene in renal carcinomaJ R Gnarra, K Tory, Y Weng, et al.
Oncogene|June 1, 1994
Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell linesY Sekido, S Bader, F Latif, et al.
Oncogene|January 1, 1994
Examination of human tumors for rhoA mutationsJ A Moscow, R He, J R Gnarra, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 1995
Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutationsD R Duan, J S Humphrey, D Y Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1996
Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor geneJ R Gnarra, S Zhou, M J Merrill, et al.
Pageof 5